Report Detail
Global Recombinant FSH Injections Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4679744 |
- 26 February, 2026 |
- Global |
- 102 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Recombinant FSH Injections market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
This report is a detailed and comprehensive analysis for global Recombinant FSH Injections market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant FSH Injections market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Recombinant FSH Injections market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Recombinant FSH Injections market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Recombinant FSH Injections market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant FSH Injections
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant FSH Injections market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Follitrope (LG Chem), GenSci, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant FSH Injections market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder
Liquid
Market segment by Application
IVF and Embryo Transfer
Infertility Treatment
Major players covered
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
GenSci
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant FSH Injections product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant FSH Injections, with price, sales quantity, revenue, and global market share of Recombinant FSH Injections from 2021 to 2026.
Chapter 3, the Recombinant FSH Injections competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant FSH Injections breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Recombinant FSH Injections market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant FSH Injections.
Chapter 14 and 15, to describe Recombinant FSH Injections sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Recombinant FSH Injections Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Powder
- 1.3.3 Liquid
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Recombinant FSH Injections Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 IVF and Embryo Transfer
- 1.4.3 Infertility Treatment
- 1.5 Global Recombinant FSH Injections Market Size & Forecast
- 1.5.1 Global Recombinant FSH Injections Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Recombinant FSH Injections Sales Quantity (2021-2032)
- 1.5.3 Global Recombinant FSH Injections Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Gonal-F (Merck)
- 2.1.1 Gonal-F (Merck) Details
- 2.1.2 Gonal-F (Merck) Major Business
- 2.1.3 Gonal-F (Merck) Recombinant FSH Injections Product and Services
- 2.1.4 Gonal-F (Merck) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Gonal-F (Merck) Recent Developments/Updates
- 2.2 Follistim (Organon)
- 2.2.1 Follistim (Organon) Details
- 2.2.2 Follistim (Organon) Major Business
- 2.2.3 Follistim (Organon) Recombinant FSH Injections Product and Services
- 2.2.4 Follistim (Organon) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Follistim (Organon) Recent Developments/Updates
- 2.3 Bravelle (Ferring)
- 2.3.1 Bravelle (Ferring) Details
- 2.3.2 Bravelle (Ferring) Major Business
- 2.3.3 Bravelle (Ferring) Recombinant FSH Injections Product and Services
- 2.3.4 Bravelle (Ferring) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Bravelle (Ferring) Recent Developments/Updates
- 2.4 Menopur (Ferring)
- 2.4.1 Menopur (Ferring) Details
- 2.4.2 Menopur (Ferring) Major Business
- 2.4.3 Menopur (Ferring) Recombinant FSH Injections Product and Services
- 2.4.4 Menopur (Ferring) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Menopur (Ferring) Recent Developments/Updates
- 2.5 Fostimon (IBSA)
- 2.5.1 Fostimon (IBSA) Details
- 2.5.2 Fostimon (IBSA) Major Business
- 2.5.3 Fostimon (IBSA) Recombinant FSH Injections Product and Services
- 2.5.4 Fostimon (IBSA) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Fostimon (IBSA) Recent Developments/Updates
- 2.6 Puregon (Organon)
- 2.6.1 Puregon (Organon) Details
- 2.6.2 Puregon (Organon) Major Business
- 2.6.3 Puregon (Organon) Recombinant FSH Injections Product and Services
- 2.6.4 Puregon (Organon) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Puregon (Organon) Recent Developments/Updates
- 2.7 BEMFOLA (Gedeon Richter)
- 2.7.1 BEMFOLA (Gedeon Richter) Details
- 2.7.2 BEMFOLA (Gedeon Richter) Major Business
- 2.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
- 2.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
- 2.8 Follitrope (LG Chem)
- 2.8.1 Follitrope (LG Chem) Details
- 2.8.2 Follitrope (LG Chem) Major Business
- 2.8.3 Follitrope (LG Chem) Recombinant FSH Injections Product and Services
- 2.8.4 Follitrope (LG Chem) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Follitrope (LG Chem) Recent Developments/Updates
- 2.9 GenSci
- 2.9.1 GenSci Details
- 2.9.2 GenSci Major Business
- 2.9.3 GenSci Recombinant FSH Injections Product and Services
- 2.9.4 GenSci Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 GenSci Recent Developments/Updates
3 Competitive Environment: Recombinant FSH Injections by Manufacturer
- 3.1 Global Recombinant FSH Injections Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Recombinant FSH Injections Revenue by Manufacturer (2021-2026)
- 3.3 Global Recombinant FSH Injections Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Recombinant FSH Injections by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Recombinant FSH Injections Manufacturer Market Share in 2025
- 3.4.3 Top 6 Recombinant FSH Injections Manufacturer Market Share in 2025
- 3.5 Recombinant FSH Injections Market: Overall Company Footprint Analysis
- 3.5.1 Recombinant FSH Injections Market: Region Footprint
- 3.5.2 Recombinant FSH Injections Market: Company Product Type Footprint
- 3.5.3 Recombinant FSH Injections Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Recombinant FSH Injections Market Size by Region
- 4.1.1 Global Recombinant FSH Injections Sales Quantity by Region (2021-2032)
- 4.1.2 Global Recombinant FSH Injections Consumption Value by Region (2021-2032)
- 4.1.3 Global Recombinant FSH Injections Average Price by Region (2021-2032)
- 4.2 North America Recombinant FSH Injections Consumption Value (2021-2032)
- 4.3 Europe Recombinant FSH Injections Consumption Value (2021-2032)
- 4.4 Asia-Pacific Recombinant FSH Injections Consumption Value (2021-2032)
- 4.5 South America Recombinant FSH Injections Consumption Value (2021-2032)
- 4.6 Middle East & Africa Recombinant FSH Injections Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Recombinant FSH Injections Sales Quantity by Type (2021-2032)
- 5.2 Global Recombinant FSH Injections Consumption Value by Type (2021-2032)
- 5.3 Global Recombinant FSH Injections Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Recombinant FSH Injections Sales Quantity by Application (2021-2032)
- 6.2 Global Recombinant FSH Injections Consumption Value by Application (2021-2032)
- 6.3 Global Recombinant FSH Injections Average Price by Application (2021-2032)
7 North America
- 7.1 North America Recombinant FSH Injections Sales Quantity by Type (2021-2032)
- 7.2 North America Recombinant FSH Injections Sales Quantity by Application (2021-2032)
- 7.3 North America Recombinant FSH Injections Market Size by Country
- 7.3.1 North America Recombinant FSH Injections Sales Quantity by Country (2021-2032)
- 7.3.2 North America Recombinant FSH Injections Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Recombinant FSH Injections Sales Quantity by Type (2021-2032)
- 8.2 Europe Recombinant FSH Injections Sales Quantity by Application (2021-2032)
- 8.3 Europe Recombinant FSH Injections Market Size by Country
- 8.3.1 Europe Recombinant FSH Injections Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Recombinant FSH Injections Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant FSH Injections Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Recombinant FSH Injections Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Recombinant FSH Injections Market Size by Region
- 9.3.1 Asia-Pacific Recombinant FSH Injections Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Recombinant FSH Injections Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Recombinant FSH Injections Sales Quantity by Type (2021-2032)
- 10.2 South America Recombinant FSH Injections Sales Quantity by Application (2021-2032)
- 10.3 South America Recombinant FSH Injections Market Size by Country
- 10.3.1 South America Recombinant FSH Injections Sales Quantity by Country (2021-2032)
- 10.3.2 South America Recombinant FSH Injections Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant FSH Injections Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Recombinant FSH Injections Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Recombinant FSH Injections Market Size by Country
- 11.3.1 Middle East & Africa Recombinant FSH Injections Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Recombinant FSH Injections Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Recombinant FSH Injections Market Drivers
- 12.2 Recombinant FSH Injections Market Restraints
- 12.3 Recombinant FSH Injections Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Recombinant FSH Injections and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Recombinant FSH Injections
- 13.3 Recombinant FSH Injections Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Recombinant FSH Injections Typical Distributors
- 14.3 Recombinant FSH Injections Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Recombinant FSH Injections. Industry analysis & Market Report on Recombinant FSH Injections is a syndicated market report, published as Global Recombinant FSH Injections Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Recombinant FSH Injections market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
